Advertisement
BPYPM vs CNS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPYPM is a Hold and CNS is a StrongBuy.
BPYPM in downward trend: price dove below 50-day moving average on October 09, 2026
BPYPM moved below its 50-day moving average on October 09, 2026 date and that indicates a change from an upward trend to a downward trend. In 26 of 45 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 58%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BPYPM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.
The Aroon Indicator for BPYPM entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 34 of 56 cases where BPYPM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 61%.
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on BPYPM as a result. In 48 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 58%.
The Moving Average Convergence Divergence (MACD) for BPYPM just turned positive on November 04, 2026. Looking at past instances where BPYPM's MACD turned positive, the stock continued to rise in 31 of 52 cases over the following month. The odds of a continued upward trend are 60%.
BPYPM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 8 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (2.412). P/E Ratio (0.000) is within average values for comparable stocks, (-2.386). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.319). Dividend Yield (0.099) settles around the average of (0.270) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (15.694).
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. BPYPM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BPYPM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.
CNS in +4.88% Uptrend, rising for three consecutive days on October 16, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CNS advanced for three days, in 182 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CNS's RSI Indicator exited the oversold zone, 13 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 52%.
The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on CNS as a result. In 50 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 60%.
The Moving Average Convergence Divergence (MACD) for CNS just turned positive on October 20, 2026. Looking at past instances where CNS's MACD turned positive, the stock continued to rise in 24 of 45 cases over the following month. The odds of a continued upward trend are 53%.
CNS moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 39 of 60 cases where CNS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 65%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 68%.
CNS broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CNS entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 33 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 39 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 52 (best 1 - 100 worst), indicating steady price growth. CNS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 91 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.
The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.387) is normal, around the industry mean (2.412). P/E Ratio (22.385) is within average values for comparable stocks, (-2.386). Projected Growth (PEG Ratio) (1.671) is also within normal values, averaging (1.319). Dividend Yield (0.037) settles around the average of (0.270) among similar stocks. P/S Ratio (6.139) is also within normal values, averaging (15.694).
CNS | ||
|---|---|---|
OUTLOOK RATING 1..100 | 10 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 93 Overvalued | |
PROFIT vs RISK RATING 1..100 | 91 | |
SMR RATING 1..100 | 33 | |
PRICE GROWTH RATING 1..100 | 52 | |
P/E GROWTH RATING 1..100 | 39 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| BPYPM | CNS | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 52% |
| Stochastic ODDS (%) | 1 day ago 61% | 1 day ago 65% |
| Momentum ODDS (%) | 1 day ago 58% | 1 day ago 60% |
| MACD ODDS (%) | 1 day ago 60% | 1 day ago 53% |
| TrendWeek ODDS (%) | 1 day ago 52% | 1 day ago 61% |
| TrendMonth ODDS (%) | 1 day ago 54% | 1 day ago 65% |
| Advances ODDS (%) | N/A | 26 days ago 60% |
| Declines ODDS (%) | 12 days ago 52% | 5 days ago 68% |
| BollingerBands ODDS (%) | 1 day ago 50% | 1 day ago 71% |
| Aroon ODDS (%) | 1 day ago 54% | 1 day ago 62% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BPYPM’s FA Score shows that 1 FA rating(s) are green while CNS’s FA Score has 1 green FA rating(s).
- BPYPM’s FA Score: 1 green, 4 red.
- CNS’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BPYPM’s TA Score shows that 4 TA indicator(s) are bullish while CNS’s TA Score has 5 bullish TA indicator(s).
- BPYPM’s TA Score: 4 bullish, 3 bearish.
- CNS’s TA Score: 5 bullish, 4 bearish.
Price Growth
BPYPM (@Investment Managers) experienced а +0.51% price change this week, while CNS (@Investment Managers) price change was +1.86% for the same time period.
The average weekly price growth across all stocks in the @Investment Managers industry was +0.00%. For the same industry, the average monthly price growth was -2.81%, and the average quarterly price growth was -1.54%.
Reported Earning Dates
CNS is expected to report earnings on Jan 27, 2027.
Industries' Descriptions
@Investment Managers (+0.00% weekly)Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.
Advertisement
BPYPM and
Correlation & Price change
A.I.dvisor indicates that over the last year, BPYPM has been loosely correlated with TROW. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if BPYPM jumps, then TROW could also see price increases.
| Ticker / NAME | Correlation To BPYPM | 1D Price Change % | ||
|---|---|---|---|---|
| BPYPM | 100% | -0.06% | ||
| TROW - BPYPM | 35% Loosely correlated | +2.22% | ||
| BEN - BPYPM | 31% Poorly correlated | +6.34% | ||
| CNS - BPYPM | 30% Poorly correlated | +3.50% | ||
| VRTS - BPYPM | 25% Poorly correlated | +10.09% | ||
| CSWC - BPYPM | 25% Poorly correlated | +0.99% | ||
More | ||||
CNS and
Correlation & Price change
A.I.dvisor indicates that over the last year, CNS has been loosely correlated with BAM. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if CNS jumps, then BAM could also see price increases.